Immunovant, Inc.
IMVT
S
|
$28.65
-0.31%
-0.31%
1.1M
|
Health Technology
(0.0% 1d) (-8.4% 1m) (76.9% 1y) (0.0% 2d) (-0.5% 3d) (1.4% 7d) (21.61% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 4,162,643,591
http://www.immunovant.com
Sec Filling | Patents | 68 employees
Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.
autoimmunity
add to watch list Paper trade email alert is off
Press-releases
Immunovant Awarded U.S. Patent for IMVT-1402
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 0.69%
H: 0.98%
C: -2.05%
imvt-1402 patent
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended December 31, 2023
Published: 2024-02-12 (Crawled : 12:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: -4.37%
H: 8.25%
C: 8.07%
financial results
Immunovant to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-03 (Crawled : 13:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: -2.03%
H: 0.64%
C: -4.39%
conference
Roivant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
Published: 2023-12-20 (Crawled : 22:00) - globenewswire.com
ROIV | $10.935 3.16% 3.06% 5M
|
Manufacturing
|
| O: 4.52%
H: 2.02%
C: 1.25%
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 11.69%
H: 0.64%
C: -3.24%
disease positive results
Immunovant Reports Positive Initial Phase 2 Results for Batoclimab in Graves’ Disease
Published: 2023-12-20 (Crawled : 22:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 11.69%
H: 0.64%
C: -3.24%
disease positive results
Immunovant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 2.92%
H: 6.63%
C: 4.32%
imvt-1402 positive potential results
Roivant Announces Positive IMVT-1402 Initial 600 mg MAD Results that Confirm Best-in-Class Potential
Published: 2023-11-28 (Crawled : 12:00) - globenewswire.com
ROIV | $10.935 3.16% 3.06% 5M
|
Manufacturing
|
| O: -0.11%
H: 0.66%
C: 0.0%
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 2.92%
H: 6.63%
C: 4.32%
imvt-1402 positive potential results
Immunovant to Present at Upcoming Investor Conferences
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: -0.8%
H: 3.04%
C: 1.33%
Immunovant Reports Financial Results and Provides Corporate Updates for the Quarter Ended September 30, 2023
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: -2.19%
H: 1.87%
C: -4.13%
financial results
Immunovant Announces Closing of Upsized Common Stock Financing and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Published: 2023-10-02 (Crawled : 21:00) - globenewswire.com
IMVT S | $28.65 -0.31% -0.31% 1.1M
|
Health Technology
|
| O: 0.0%
H: 2.16%
C: -1.04%
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10